Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Rigaku Launches New X-Ray Microscope

Published: Tuesday, February 18, 2014
Last Updated: Tuesday, February 18, 2014
Bookmark and Share
Rigaku’s nano3DX X-ray microscope debuted at ACMM23 & ICONN2014.

Rigaku has announced the release of the nano3DX X-ray microscope, which debuted at ACMM23 & ICONN2014 (the 23rd Australian Conference on Microscopy and Microanalysis and the International Conference on Nanoscience and Nanotechnology).

The nano3DX is a new product for Rigaku, which has a long history and significant expertise in analytical X-ray related technologies such as X-ray diffraction (XRD), X-ray fluorescence (XRF) and non-destructive testing (NDT). It is a true X-ray microscope (XRM) with the ability to measure relatively large samples at high resolution.

As an X-ray microscope, the nano3DX images the entire sample from multiple angles. In doing so, it can reconstruct a 3D image at 0.27 µm resolution. The computer model allows the user to view sections at any point on any plane, providing valuable insights into the structure of the sample.

The secret behind the Rigaku nano3DX is the high-power rotating anode and high-resolution optics coupled with sub-micron CCD technology. This combination is capable of fast data collection and has the ability to switch anode materials rapidly to optimize data acquisition. Furthermore, the magnification occurs in the detector using true microscope elements.

The geometry of the system allows the sample to be located very close to the high-resolution detector, which provides near-parallel beam optics. This design results in improved instrument stability, which prevents smearing, allows for faster data collection times and ultimately yields the highest resolution X-ray microscope in its class.

One of the other advantages of the nano3DX over other instruments is its ultra-wide field of view. The nano3DX is able to measure volumes up to 25 times larger in a single scan compared to other systems at similar resolutions in comparable time frames.

Primary anode materials used in the nano3DX are copper, chromium and molybdenum. The choice of these anode materials gives the system the flexibility to optimize the X-rays for penetration and contrast based on the atomic weights of materials present in the sample.

X-ray microscopy is suited to all kinds of materials, from low density materials such as biological samples to high density materials such as ceramics and steels. XRM is even suitable for materials with low absorption contrast, like CFRPs and pharmaceuticals.

Applications for the nano3DX are many and varied, from materials science to electronics and semiconductors to mining and minerals exploration to life sciences and pharmaceuticals.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rigaku Raman Technologies Announces Rebrand to Rigaku Analytical Devices
Rigaku Analytical Devices sets benchmark in spectroscopy industry with portfolio of powerful customizable handheld and portable spectroscopic analyzers.
Friday, June 05, 2015
Rebrand for Rigaku Raman Technologies
Rigaku Raman Technologies has announced it will formally operate as Rigaku Analytical Devices.
Monday, June 01, 2015
Rigaku Announce New President & COO
Company appoints Mr. Yoichi Yokomizo as Chief Operating Officer of RAH.
Tuesday, April 07, 2015
Rigaku to Acquire Agilent’s X-Ray Diffraction Business
Company plans to combine XRD with its existing crystallography business to form a new business unit.
Wednesday, April 01, 2015
European Crystallography Meeting delegates Raise Money for Charity
Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research.
Wednesday, October 02, 2013
Rigaku and Emerald Bio Announce Strategic Alliance
Partnership to broaden customer solutions in protein crystallography.
Thursday, August 01, 2013
Analysis of Sulfur and Chlorine in Oil by Energy Dispersive X-ray Fluorescence
Monitoring the sulfur and chlorine content is critical in the production of various oils and oil products.
Wednesday, May 15, 2013
Texas State University Acquires Rigaku SCXmini Chemical Crystallography Instrument
The University has purchased the benchtop small molecule XRD crystallography instrument for Cyber-enabled for cyber-enabled teaching and research.
Thursday, January 08, 2009
Monash University Purchases Rigaku CrystalMation system for The Protein Crystallography Unit
The system is chosen in support of macromolecular crystallographic studies carried out by researchers at Monash University and their collaborative partners.
Friday, September 26, 2008
Rigaku Wins "Most Innovative New Technology" Award for CrystalMation™ and Desktop Minstrel™ UV Products
Company receives award for the Rigaku Desktop Minstrel UV system and Rigaku CrystalMation system at the ELRIG Protein Crystallography Conference.
Wednesday, April 23, 2008
Rigaku Sponsors Carl Brändén Award
The 2007 Carl Brändén Award was presented to Prof. Lubert Stryer for his exceptional contributions to education in biochemistry and molecular biology.
Monday, June 04, 2007
Rigaku Leads in Protein Structure Productivity Based on Analysis of Protein Data Bank Submissions
Data show that structures solved with Rigaku home laboratory X-ray generators comprised 17% of all submitted structures for 2005.
Wednesday, March 07, 2007
Rigaku Launches new Corporate Website
The website integrates all Rigaku products and business units with a common look and feel for an enhanced Internet browsing experience.
Wednesday, November 01, 2006
Rigaku Announces Reorganization
Rigaku Americas Corporation became the operating entity in charge of North America.
Tuesday, October 18, 2005
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos